-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VGJhHeT0BMMbzc4h+Jv2pvZVPhflOgkAptApSLjkjeP8Of68UEZ5Xg5wHmf5+0aE
 AITTlClBbNIyvgRvHV/Igg==

<SEC-DOCUMENT>0001212374-05-000010.txt : 20050204
<SEC-HEADER>0001212374-05-000010.hdr.sgml : 20050204
<ACCEPTANCE-DATETIME>20050204201421
ACCESSION NUMBER:		0001212374-05-000010
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041103
FILED AS OF DATE:		20050204
DATE AS OF CHANGE:		20050204

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ZIERING MARILYN
		CENTRAL INDEX KEY:			0001002106

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09957
		FILM NUMBER:		05578587

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		2137760180

	MAIL ADDRESS:	
		STREET 1:		5700 W 96TH STREET
		STREET 2:		C/O DIAGNOSTIC PRODUCTS CORP
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90045

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DIAGNOSTIC PRODUCTS CORP
		CENTRAL INDEX KEY:			0000702259
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				952802182
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5210 PACIFIC CONCOURSE DRIVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90045
		BUSINESS PHONE:		3106458200

	MAIL ADDRESS:	
		STREET 1:		5210 PACIFIC CONCOURSE DRIVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90045
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2004-11-03</periodOfReport>

    <dateOfOriginalSubmission>2004-11-18</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000702259</issuerCik>
        <issuerName>DIAGNOSTIC PRODUCTS CORP</issuerName>
        <issuerTradingSymbol>DP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001002106</rptOwnerCik>
            <rptOwnerName>ZIERING MARILYN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DIAGNOSTIC PRODUCTS CORP</rptOwnerStreet1>
            <rptOwnerStreet2>5210 PACIFIC CONCOURSE DRIVE</rptOwnerStreet2>
            <rptOwnerCity>LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90045</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Senior Vice President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-11-03</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>G</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>225</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4762992</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Trust</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">3956 Shares, Indirect, by 401K
4886 Shares, Indirect, by 401K of Deceased Husband</footnote>
        <footnote id="F2">Amendment filed to correct end of period holdings. As trustee and beneficiary of revocable trust per rule 16a-8(b), the trust transactions are reported by reporting person instead of trust.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>James L. Brill, Authorized Signer</signatureName>
        <signatureDate>2005-02-04</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----